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Abstract
Clostridium difficile infection (CDI) is the leading cause of hospital and community-acquired antibiotic-associated diarrhoea
and currently represents a significant health burden. Although the role and contribution of C. difficile toxins to disease
pathogenesis is being increasingly understood, at present other facets of C. difficile-host interactions, in particular, bacterial-
driven effects on host immunity remain less studied. Using an ex-vivo model of infection, we report that the human
gastrointestinal mucosa elicits a rapid and significant cytokine response to C. difficile. Marked increase in IFN-c with modest
increase in IL-22 and IL-17A was noted. Significant increase in IL-8 suggested potential for neutrophil influx while presence
of IL-12, IL-23, IL-1b and IL-6 was indicative of a cytokine milieu that may modulate subsequent T cell immunity. Majority of
C. difficile-driven effects on murine bone-marrow-derived dendritic cell (BMDC) activation were toxin-independent; the
toxins were however responsible for BMDC inflammasome activation. In contrast, human monocyte-derived DCs (mDCs)
released IL-1b even in the absence of toxins suggesting host-specific mediation. Infected DC-T cell crosstalk revealed the
ability of R20291 and 630 WT strains to elicit a differential DC IL-12 family cytokine milieu which culminated in significantly
greater Th1 immunity in response to R20291. Interestingly, both strains induced a similar Th17 response. Elicitation of
mucosal IFN-c/IL-17A and Th1/Th17 immunity to C. difficile indicates a central role for this dual cytokine axis in establishing
antimicrobial immunity to CDI.
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Introduction
In the late 1970s, Clostridium difficile, a Gram-positive spore-
forming anaerobe was identified as the causative agent of
pseudomembranous colitis (PMC), a sporadic but life-threaten-
ing gut inflammatory condition [1,2]. Alarmingly, since 2003 a
new lineage of highly virulent C. difficile strains has emerged to
cause outbreaks of increased disease severity in North America
and Europe. Patients infected with these PCR-ribotype 027
strains have more severe diarrhoea, higher mortality and more
recurrences [3]. Currently CDI is considered the leading cause
of hospital and community-acquired antibiotic-associated diar-
rhoea in the western world [3–5]. This is reflected in the rates
of morbidity and mortality with 36,000 cases registered with the
UK health protection agency in 2010 alone (www.statistics.gov.
uk). CDI is increasingly seen in patient groups which prior to
2000 were considered to be at low-risk, i.e those with no recent
exposure to antibiotics and in young adults [6]. A higher
prevalence of CDI in patients with Inflammatory Bowel Disease
(IBD) [7] and Cystic Fibrosis [8] has also been noted.
A better understanding of the microbial pathogenesis of the new
virulent strains is a current imperative and significant progress has
been made in recent years. Virulent strains can produce up to
three toxins: toxin A (TcdA) an enterotoxin, toxin B (TcdB) a
cytotoxin and a binary toxin (CDT). In-vitro and in-vivo studies
utilising purified/recombinant TcdA and TcdB, or more recently
specific tcdA/tcdB insertions have shed light on the probable
contribution of each toxin to disease pathogenesis [9,10]. By
contrast, our current understanding of host immunity to C. difficile
remains rudimentary, particularly as the potent effects of the
toxins obscure more subtle host immunity interactions. Our
research aims to elucidate C. difficile-host interactions that allow
elicitation of protective immunity versus generation of immunopa-
thology.
In the present study we characterised the human gastrointestinal
(GI) mucosal cytokine milieu generated in response to two well
described clinical C. difficile isolates, R20291 a hypervirulent PCR-
ribotype 027 [11] and the fully sequenced strain 630 PCR-
ribotype 012 [12]. We found that control colonic tissue had the
ability to elicit rapid (as early as 3 h post-infection) and significant
cytokine responses to the two strains tested. These observations are
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important as the mucosal cytokine profile documented is likely to
reflect cellular events operative during the acute phase of CDI in
humans.
Dendritic cells (DCs) are potent antigen-presenting cells that
sense and relay microbial presence to naı¨ve CD4 T cells which,
upon activation, differentiate into various effector and regulatory
subtypes. In a healthy individual their concerted action culminates
in successful microbial clearance while registering immunological
memory. Although the effect of purified C. difficile TcdA and
surface layer proteins (SLPs) on DC function [13–15] has been
reported, no data is currently available on CDI-mediated DC
function and T cell immunity.
Herein, murine bone-marrow-derived and human monocyte-
derived DCs (BMDC & mDC) were cultured in the presence of
wild-type (WT) strains R20291 and 630. In addition, BMDC
responses to tcdA, tcdB and tcdA/tcdB mutant strains were
characterised. The WT strains caused an increase in BMDC
maturation marker status and cytokine production; interestingly
the majority of parameters measured were not significantly
different in response to infection with the toxin-deficient mutants
when compared to the WT suggesting that DC activation was
mainly bacterial-driven and toxin-independent. The toxin(s) had
the greatest impact on IL-1b release, as its secretion was abrogated
in response to the double tcdA/tcdB knockout (KO) strain.
Recombinant TcdA and TcdB elicit potent macrophage IL-1b
secretion by activating the inflammasome complex; this process is
known to occur via Nlrp3 engagement [16]. Interestingly, when we
conducted infections in Nlrp3 KO BMDCs, we found minimal
reduction in IL-1b levels compared to WT BMDCs; our
observations suggests that C. difficile has the capacity to engage
other, as yet unidentified NLRs during BMDC activation.
Finally, infection with WT strains generated dual Th1/Th17
immunity with R20291 eliciting a significantly more robust Th1
response compared to the 630 strain. Collectively, our study
highlights IFN-c as the central host defence cytokine against C.
difficile, with IL-22 and IL-17A contributing to the antimicrobial
shield. Our data also adds to the growing evidence that the toxin-
specific effect on the inflammasome axis may represent a potential
therapeutic target for alleviating some of the immunopathology
associated with toxigenic C. difficile strains.
Results
Ex-vivo Mucosal Cytokine Responses to C. Difficile Strains
R20291 and 630
The conventional in-vitro organ culture (IVOC) method that
utilises colonic pinch biopsies has been employed by several
investigators to study interaction of enteropathogens with the
human gastrointestinal mucosa [17–19]. To delineate the mucosal
cytokine milieu generated in response to C. difficile, colonic biopsy
tissue(s) was co-cultured with strains R20291 [hypervirulent
ribotype 027 (TcdA+/TcdB+/CDT+) isolated from multi-ward
outbreaks in Stoke Mandeville Hospital, UK in 2007] and 630
[ribotype 012 (TcdA+/TcdB+/CDT-) isolated from an outbreak of
severe CDI in Zurich in 1985] for 6 h. Upon infection, a marked
increase in IL-8 was observed (Fig. 1A). Interestingly, significant
inter-strain variation was noted with R20291 mediating greater
chemokine release than 630 (p.0.05). IL-1b secretion showed a
Figure 1. Ex-vivo mucosal cytokine responses to C. difficile infection. Macroscopically normal and matched multiple colonic biopsies (30
individuals with mean age of 10.46 SD of 4.7) were infected with C. difficile strains R20291 and 630 (56108) for 6h. Post-infection IL-8 (A), IL-1b (B), IL-
6 (C), IFN-c (D), IL-17A (E) and IL-22 (F) were quantified by ELISA. Bars represent median levels. *p,0.05, **p,0.01 and ***p,0.001 represent
significant difference from uninfected controls and
ˆ
p,0.05 represent significant inter-strain difference. Data was analysed using a Mann–Whitney U
test.
doi:10.1371/journal.pone.0069846.g001
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similar trend (Fig. 1B). IL-6 was detectable in uninfected colonic
tissue (Fig. 1C); the increase upon infection was however not as
marked as that seen for IL-8 and IL-1b. Infection led to a robust
(median 700–850 pg/ml) IFN-c response (Fig. 1D). The effect on
IL-17A expression was modest (Fig. 1E; median 50–60 pg/ml),
whilst a significant increase in IL-22 was noted (Fig. 1F; median
,200 pg/ml).
Overall, the human GI mucosa rapidly responded to C. difficile
by secreting significant amounts of IL-8, IL-1b and IFN-c. The
consistent greater cytokine response(s) to R20291 suggested that
early host-pathogen interactions also render the GI mucosal
immune system with the ability to not only distinguish, but also to
respond, in a strain-specific manner.
C. Difficile-mediated Effects on Murine bone-marrow-
derived Dendritic Cell (BMDC) Activation
To decipher C. difficile-mediated DC-T cell crosstalk we
employed murine cells as these provide a genetically homogenous
model system. Time-dependent effects on BMDC activation in
response to WT R20291, WT 630 and 630 toxin isogenic mutant
strains were investigated. The intoxication potential of WT 630
and its mutant strains was routinely tested prior to co-culture
experiments [10] (Fig. S1A-D in File S1). Modulation of DC
maturation status (data not shown) and cytokine response was
measured (Fig. 2 & 3). As the toxin mutants were constructed in
strain 630Derm (Table S1 in File S1) this strain was also included
in the analysis. Strain 630Derm is an erythromycin sensitive
derivative of strain 630 which was obtained by serial passage [20]
and thus may have accumulated mutations compared to 630 [21].
Analysis of the toxin mutants compared to their parent strain
enabled us to define bacterial-specific interactions in the absence
of the toxins.
Effect of R20291 and 630 Infections on BMDC Maturation
Markers and Cytokine Responses
The capacity of C. difficile to modulate BMDC maturation
(MHC class II), CD40 and co-stimulatory CD80 and CD86
expression was investigated. Strains R20291, 630 and 630Derm
increased MHC class II and CD40 expression, however this
increase did not reach statistical significance and no difference in
the magnitude of the responses was apparent with the mutant
strains (data not shown). Next, we studied the effect of C. difficile on
gene and protein expression of candidate cytokines involved in
BMDC function (Fig. 2 & 3). IL-12 family members including IL-
12, IL-23 and IL-27 are critical determinants of downstream T cell
response(s). Heterodimeric IL-12 constitutes subunits p35/p40, IL-
23 p19/p40 and IL-27 p28/EBI3. Strains R20291 and 630 both
induced p35, p40, p19 and p28 mRNA expression in a time-
dependent manner (Fig. 2A–D), with R20291 mediating a
statistically significant increase compared to 630, which was most
evident 6h post-infection. The increase in EBI3 mRNA did not
show a statistical difference between the two strains (Fig. 2E).
Interestingly, while eliciting differential responses to the IL-12
family, both strains mediated a similar increase in IL-10 and IL-1b
mRNA expression (Fig. 2F & G).
R20291 caused a significant increase not only in IL-12, IL-23
and IL-27 mRNA levels but this was also seen at the protein level
(Fig. 3A–C). In comparison, 630 elicited modest levels of all three
cytokines. Overall, the absence of toxins did not have a significant
impact on the expression of the IL-12 family. Taken together, this
data indicates that C. difficile strains modulate DC IL-12 members
differentially at the transcriptional level; this is an important
observation as it suggests that host innate and downstream
adaptive immunity may vary depending upon the infecting strain.
Unlike the inter-strain variation observed in IL-12/IL-23/IL-27
levels, IL-10, a potent anti-inflammatory cytokine was induced by
the WT and 630Derm strains to a similar extent, and no effect of
toxin deletion was noted (Fig. 3D).
We also investigated the effect of C. difficile on BMDC IL-b
protein levels (Fig. 3E). A marked increase (median ,2000–
3000 pg/ml) in IL-1b secretion was observed in response to the
WT strains, with R20291 exerting significantly greater effect
compared to 630 and 630Derm (Fig. 3E). IL-1b secretion was
reduced in response to the tcdA mutant strain compared to the
parental 630Derm and importantly, was abrogated in response to
the tcdA/tcdB double-toxin mutant. These observations define the
C. difficile toxins as central regulators of IL-1b secretion. Overall,
our observations suggest that C. difficile mediates BMDC activation
by engaging toxin-independent mechanism(s) to regulate the IL-12
family and IL-10 responses; in contrast, toxin-dependent mech-
anism(s) drive IL-1b secretion.
C. Difficile Strains R20291 and 630 Mediate BMDC
Inflammasome Activation
Although studies have implicated Nlrp3 in C. difficile toxin-
mediated inflammasome activation in macrophages [16]; the
identity of components involved in BMDC inflammasome
function during CDI is unknown. Inflammasome activation
culminates in autolytic cleavage of pro-caspase-1 to caspase-1,
the enzyme responsible for the cleavage of pro-IL-1b to its
bioactive form. Strains were co-cultured with WT, Nlrp3 and ASC
KO BMDCs. Cellular caspase-1, pro-IL-1b/IL-1b protein levels
and IL-1b secretion were quantified by western blotting (Fig. 4A)
and ELISA respectively (Fig. 4B & C). Strains R20291 and 630
showed no major difference in their ability to generate active
caspase-1(p10) in WT and Nlrp3 KO BMDCs (Fig. 4A) however,
this ability was markedly inhibited in ASC KO BMDCs (Fig. 4A &
B), indicating that ASC is a critical component of C. difficile-
mediated BMDC inflammasome activation. In contrast to the
630Derm tcdA/tcdB double-toxin mutant in which IL-1b secretion
was absent, infection with the single toxin mutant strains showed
no significant difference compared with the parental strain in WT
and Nlrp3 KO BMDC (Fig. 4C). Collectively, these experiments
suggest that strains R20291 and 630 mediate caspase-1 cleavage in
an ASC-dependent manner whilst utilising other upstream NLRs
in the absence of Nlrp3.
R20291 and 630-mediated Effects on IL-10 and IL-1b
Protein Secretion by Human Monocyte-derived DCs
As strains R20291 and 630 modulated BMDC cytokine
responses in a toxin-independent and dependent fashion (Fig. 2
& 3), we next examined if similar mechanism(s) were also operative
during human infection. For this purpose, monocyte-derived DCs
(mDCs) from healthy volunteers were infected with the various
bacterial strains and IL-10 and IL-1b protein analysed; these two
cytokines were chosen as markers of toxin-independent and
dependent regulation. The IL-10 protein level in response to WT
and mutant strains was similar amongst the donors tested
suggesting that C. difficile does indeed modulate IL-10 expression
in a toxin-independent manner (Fig. 5A). R20291 showed a trend
for greater IL-1b secretion compared to 630, and an absence of
the single toxin had minimal effect. Interestingly, unlike BMDC
IL-1b responses (Fig. 3E) complete abrogation of IL-1b in
response to the double-toxin mutant strain was not seen in mDCs
(Fig. 5B), indicating that unlike the murine model, toxin-
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PLOS ONE | www.plosone.org 3 July 2013 | Volume 8 | Issue 7 | e69846
independent bacterial factors may influence inflammasome
function in humans.
R20291 and 630 Infected BMDCs Generate a Cytokine
Milieu That Favours Dual Th1/Th17 Immunity
DC-T cell crosstalk is a critical determinant for T cell
proliferative capacity and T cell effector function. We investigated
T cell proliferation in response to paraformaldehyde (PFA)-fixed
R20291 and 630-infected BMDCs in two model systems. Infected
BMDCs were co-cultured with CFSE-labelled splenocytes in the
presence of anti-CD3/CD28, or with CFSE-labelled naı¨ve CD4 T
cells from OT-II transgenic mice in the presence of OVA (peptide
323–339) [22,23]. 72–96 h post co-culture, T cell proliferation was
quantified by flow-cytometry (Fig. 6A). R20291 and 630-infected
BMDCs induced a similar rate of T cell proliferation in both cell
systems (Fig. 6B & C). Next, T cell cytokine response(s) were
measured (Fig. 7). The number of IFN-c expressing T cell
generated in response to R20291 was significantly greater than
seen with strain 630 (Fig. S2A in File S1). This difference was also
observed at the protein level (median ,1000 pg/ml versus
,450 pg/ml; Fig. 7A). The increase in IL-17A expressing CD4+
T cells and IL-17A protein levels was found to be similar in
response to both strains (Fig. S2B in File S1 & 7B). In summary, C.
difficile infection mediated potent Th1 and Th17 immunity and the
magnitude of the IFN-c response was found to be strain-specific. T
cell derived IL-10 levels did not significantly differ between the two
infectious agents (Fig. 7C). Low IL-4 levels suggested that Th2
immunity plays a minimal role (Fig. 7D). Interestingly, strain 630
showed a greater propensity for IL-2 production compared to
R20291 (Fig. 7E).
Discussion
Despite major scientific breakthroughs in the last century,
infectious diseases remain a major global threat to health. The
continuous and rapid evolution of bacteria can promote the
sudden emergence of strains with increased virulence which poses
a new threat to human health. The recent rapid global spread of
CDI is one such example. To improve infection control and
human wellbeing, greater insight into C. difficile-host interactions is
warranted. Utilising both murine and human model systems, we
present novel findings that significantly extend our understanding
of C. difficile-mediated crosstalk with the host immune system.
Analysis of the GI mucosal cytokine milieu in the first few hours
of C. difficile infection revealed robust IL-8 induction (Fig. 1A) with
comparatively weak IL-17A response(s) (Fig. 1E) suggesting that
the former may play a more crucial role in mediating early
neutrophil recruitment, a cellular event increasingly recognised as
necessary for C. difficile containment. Interestingly, Hasegawa and
colleagues [24] reported a minimal role for IL-17A in the acute
phase of murine C. difficile infection. C. difficile-mediated DC-T cell
interactions however did lead to marked Th17 immunity (Fig. 7B)
emphasising that this cytokine axis may contribute to infection
control and/or disease pathogenesis in the chronic phase of
infection. Future work must determine if this cytokine family
contributes to the dramatic neutrophil influx seen in PMC, a
potential serious side-effect of CDI.
Figure 2. Time-dependent effects of C. difficile R20291 and 630 infection on BMDC cytokine mRNA expression. BMDCs were infected
with bacterial cultures at an MOI of 10 and mRNA expression of IL-12 family members; p35 (A), p40 (B), p19 (C), p28 (D), EBI3 (E), also IL-10 (F) and IL-
1b (G) was quantified by real-time PCR. Data is presented as fold increase compared to expression in uninfected control cells. Data represent mean6
SEM, n = 3. *p,0.05, **p,0.001, and ***p,0.001 represent significant inter-strain difference. P values were obtained using ANOVA with Bonferroni
post-test analysis.
doi:10.1371/journal.pone.0069846.g002
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Infection with strains R20291 and 630 also mediated significant
IL-1b secretion in the ex-vivo model of infection (Fig. 1B). To date,
C. difficile toxins and SLPs have been implicated in mediating IL-
1b secretion [13,16]. To the best of our knowledge the present
study is the first to characterise innate immunity in response to C.
difficile infection. The availability of isogenic mutants lacking
individual and both toxins has allowed us to make several novel
findings. Firstly, elicitation of similar levels of IL-1b in response to
630Derm and its tcdB isogenic mutant strain (Fig. 3E) suggests that
expression of a single toxin is sufficient to trigger inflammasome
activation, as complete abrogation of function was only noted
during infection with the double-toxin mutant strain. Identification
of mechanisms responsible for the reduced IL-1b levels in response
to strain 630Derm tcdA is currently under investigation. Secondly, it
is important to note that IL-1b release from human mDCs occurs,
albeit at lower levels, even in the absence of toxins (Fig. 5B). This
data supports the notion that toxin-independent bacterial deter-
minants may participate in crosstalk with the inflammasome.
Thirdly, we found redundancy in the role of Nlrp3 function in
mediating bioactive IL-b production (Fig. 4B & C) indicating that
C. difficile has the ability to engage other NLR family members in
initiating BMDC inflammasome activation.
A potent mucosal and T cell IFN-c response was recorded
during infection (Fig. 1D & 7A). Our observations place IFN-c as
the central host defence cytokine with IL-22 forming an important
component of the early antimicrobial defence (Fig. 1F). Cells
responsible for mucosal IFN-c and IL-22 production require
identification.
The differential effect on BMDC IL-12 family with minimal
effect on IL-10 and IL-1b expression during infection with the two
WT strains was a surprising finding (Fig. 2 & 3). These
observations suggest that C. difficile has evolved mechanism(s) that
allow it to specifically manipulate the IL-12 axis and consequently
downstream immunity. Although no significant difference in T cell
proliferative responses was noted (Fig. 6), impact of BMDC
cytokine milieu on Th1 immunity was apparent. R20291 infection
led to a .2-fold increase in the percentage of IFN-c expressing T
cells and cytokine levels (Fig. S2A in File S1 & 7A). In contrast,
Th17 immunity was found to be similar (Fig. S2B in File S1 & 7B).
Interestingly, strain 630 mediated significantly greater IL-2
responses compared to R20291 (Fig. 7E). IL-2 is a pleiotropic
cytokine involved in many aspects of T cell homeostasis including
proliferation, differentiation, polarisation and T regulatory func-
tion.
In summary, we propose that C. difficile strains have evolved to
actively modulate DC-T cell crosstalk, an outcome that is likely to
be dictated by the genetic content of both the bacterium and the
host. In addition, the arsenal of toxins harboured by a particular
infecting strain may differentially affect inflammasome activation
contributing to the variable severity of C. difficile infections seen in
humans.
Figure 3. C. difficile-mediated effects on BMDC cytokine production. BMDCs were infected with C. difficile cultures at an MOI of 10 and IL-12
(A), IL-23 (B) IL-27 (C), IL-10 (D) and IL-1b (E) was measured 8 h post-infection. 1 mg/ml LPS stimulation served as positive control. Data represent
mean 6 SEM of duplicate samples and are representative of three individual experiments. */‘p,0.05, ‘‘p,0.01 and ***/‘‘‘p,0.001 represent
significant difference from uninfected cells and significant inter-strain difference. P values were obtained using ANOVA with Bonferroni post-test
analysis.
doi:10.1371/journal.pone.0069846.g003
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Figure 4. C. difficile toxins trigger BMDC IL-1b release by activating an ASC-containing inflammasome. BMDCs from WT C57BL/6
(genetically Nlrp1 deficient) mice and mice deficient in Nlrp3 and ASC were infected with C. difficile strains at an MOI of 10. Pro- and active caspase-1
(45 & 10 kDa, respectively) and pro- and mature IL-1b (31 & 17 kDa, respectively) release 8h post-infection was quantified by western blotting. 5 mM
ATP served as a positive control (A). Quantification of IL-1b secretion in infected WT, Nlrp3 and ASC KO BMDC 8h post-infection. Data is represented
as mean 6 SEM, n = 4. ***p,0.001 represents significant difference from uninfected cells, ‘p,0.05 and ‘‘‘/’p,0.001 represent significant WT and
Nlrp32/2 difference from ASC2/2. P values were obtained using ANOVA with Bonferroni post-test analysis (B & C).
doi:10.1371/journal.pone.0069846.g004
Figure 5. C. difficile-mediated effects on human monocyte-derived DC IL-10 and IL-1b production. Human mDCs from nine healthy
donors were stimulated with C. difficile at an MOI of 10. IL-10 (A) and IL-1b (B) secretion measured 8h post-infection. **p,0.01 and ***p,0.001
represent significant difference from uninfected control cells. Data was analysed using Mann-Whitney U test.
doi:10.1371/journal.pone.0069846.g005
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Materials and Methods
Ethics Statement
Ethical approval for obtaining mucosal biopsies from patients
undergoing routine endoscopic procedure was granted by the
Institute of Child Health/Great Ormond Street Hospital (GOSH)
Research Ethics Committee (06/Q0508/26). Written informed
consent was provided by the legal guardians of the study
participants. Blood samples in this study were collected from
healthy adult laboratory volunteers approved by the Institute of
Child Health Human Tissue Act Review Board. Written informed
consent provided by all donors was recorded in accordance with
Research Governance and Ethical Regulations of the Institute of
Child Health.
C57BL/6 wild-type (WT) mice were purchased from The
Jackson Laboratory (Maine, USA) and housed at the Institute of
Child Health animal facilities. Approval for animal studies was
obtained from University College London Ethics Committee. All
experiments were performed according to the United Kingdom
Home Office guidelines. NALP3 and ASC deficient murine
samples were kindly provided by Dr Panagiotis Tourlomousis
(University of Cambridge, UK). Ethical approval was granted by
the University of Cambridge Ethics Committee and carried out
under UK Home Office project license number 80/2135. OT-II
transgenic mice splenic samples were from existing collections
kindly given by Dr David Escors (University College London, UK)
with the approval of the University College London Ethics
Committee.
Reagents
Brain Heart Infusion (BHI) Agar, BHI broth, C. difficile selective
supplement and difibrinated horse blood were from Oxoid,
Basingstoke, UK. Cysteine, NCTC-135 medium, gentamicin,
red blood cell lysing buffer and lipopolysaccharides (LPS) from
Figure 6. Splenocyte and Naı¨ve CD4+ T cell proliferation in response to C. difficile-stimulated BMDCs. WT BMDCs were infected with
PFA-fixed C. difficile strains at an MOI of 50. 24 h post-infection, infected BMDCs were co-cultured with CFSE-labelled splenocytes in the presence of
anti-CD3/CD28. Proliferation of CD4+ gated cells 96 h post stimulation (A). Quantification presented as percentage of proliferating cells (B). Infected
BMDCs were co-cultured with CFSE-labelled naı¨ve CD4+ T cells from OT-II transgenic mice in the presence of OVA323–339 and T cell proliferation was
analysed (C). 1 mg/ml LPS utilised as a reference stimulus. ***p,0.001 represent significant difference from uninfected control cells. Data was
analysed using ANOVA with Bonferroni post-test.
doi:10.1371/journal.pone.0069846.g006
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Escherichia coli 0111:B4 were obtained from Sigma-Aldrich, Poole,
UK. Dulbecco’s Modified Eagle Medium with GlutaMAX- I
(DMEM), Iscove’s Modified Dulbecco’s Medium (IMDM),
Roswell Park Memorial Institute (RPMI) 1640, PBS, trypsin-
EDTA, 2-Mercaptoethanol and recombinant mouse Granulocyte
Macrophage-Colony Stimulating Factor (GM-CSF) were from
Invitrogen/Gibco, Paisley, UK. All cell culture media were
supplemented with 10% fetal calf serum (FCS), 1% L-glutamine,
1% penicillin-streptomycin solution and 1% non-essential amino
acids also obtained from Invitrogen/Gibco.
Anti-Mouse CD80 PE-Cy5, CD86 FITC, MHC Class II FITC,
CD40 PE, CD4 PE, IFN-c PerCP-Cy5.5 and IL-17A FITC were
from eBioscience, Hatfield, UK. Antibodies against caspase-1(p10)
and IL-1b were acquired from Santa Cruz Biotechnology, inc.,
USA. Secondary polyclonal rabbit anti-mouse and polyclonal goat
anti-rabbit were from Dako, Denmark.
Bacterial Strains and Growth Conditions
C. difficile strains and mutants used in this study are described
(Table S1 in File S1). Bacterial strains were cultured on BHI Agar
supplemented with 5% difibrinated horse blood or pre-equilibrat-
ed BHI broth containing C. difficile selective supplement (Oxoid)
and 0.05% cysteine. All bacterial cultures were grown in an
anaerobic chamber (Don Whitley Scientific, Shipley, UK) in an
atmosphere of 10% CO2, 10% H2, and 80% N2 at 37uC.
Cell Cytoxicity Assay
Human colonic epithelial cell-line HT-29 (ATCC, HTB-38),
and African green monkey kidney cells (Vero cells, ATCC, CCL-
81) were seeded at a concentration of 1.56105 and 0.56106/ml,
respectively. Semi-confluent HT-29 and confluent Vero cells were
co-cultured with 2-fold serially diluted filter-sterilised bacterial
supernatants. The cytopathic effect (CPE) was determined by
comparing infected cells to uninfected control cells scoring each
dilution on a scale from 0 to +4.
In-Vitro Organ Culture (IVOC)
Pinch biopsies from patients (30 individuals, mean age 10.46
SD of 4.7) were obtained during routine endoscopy. Tissue was
oriented with the mucosal surface upwards and mounted on sterile
foam supports in 12 well plates. The foams were saturated with
IVOC media consisting of complete DMEM media supplemented
at ratio of 1:1 with NCTC-135 medium [25]. The explants were
inoculated with 56108 C. difficile at 37uC in 5% CO2 humidified
incubator for 3–6 h.
Western Blotting
Bacterial cells and infected-BMDC were washed with ice-cold
PBS and lysed in Laemmli buffer (0.5 M Tris-HCl pH 6.8, 10%
SDS, glycerol, 0.1% bromphenol blue, 2.5–5% b-mercaptoetha-
nol) and subjected to 15% SDS-PAGE prior to transfer onto a
PVDF membrane (Amersham Hybond, GE Healthcare, Little
Chalfont, England). Membranes were incubated with appropriate
primary antibodies at 4uC overnight prior to exposure to
secondary antibodies and detection was by enhanced chemilumi-
nescence (ECL) (Amersham ECL, GE Healthcare).
Figure 7. Generation of Th1/Th17 mediated immunity in response to C. difficile in an in-vitro murine model system. WT BMDCs were
infected with PFA-fixed C. difficile strains. 24 h post-infection, stimulated BMDCs were co-cultured with WT splenocytes in the presence of anti-CD3/
CD28. 96 h post co-culture, secreted cytokines IFN-c (A), IL-17A (B), IL-10 (C), IL-4 (D) and IL-2 (E) were measured by ELISA. 1 mg/ml LPS stimulation
served as reference control. Data represent mean 6 SEM, n = 3. */‘p,0.05, **/‘‘p,0.01 and ***p,0.001 represent significant difference when
compared to uninfected control cells and significant inter-strain difference, respectively. P values were obtained using ANOVA with Bonferroni post-
test analysis.
doi:10.1371/journal.pone.0069846.g007
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Generation and Infection of Murine Bone-marrow-
derived DC (BMDC)
Bone-marrow from the femur and tibia of C57BL/6 WT,
NALP3/Nlrp3 and ASC knockout (KO) mice was flushed with
PBS/2%FCS containing 10 mg/ml gentamicin. The cells were
depleted of red blood cells using 1 ml/pair of legs red blood cell
lysing buffer. Cells were resuspended in IMDM containing 2, b-
mercaptoethanol, gentamycin and GM-CSF. Cells were fed every
2 days. On day 7, cells were harvested by collecting non-adherent
cells and detaching adherent cells with 2 mM EDTA-PBS
(Ambion, Warrington, UK). Cells were washed and resuspended
in complete RPMI without antibiotics and seeded at a density of
16106/ml prior to infection with C. difficile strains at a multiplicity
of infection (MOI) of 10. Cytokine protein secretion was measured
by ELISA according to the manufacturer’s instructions
(eBioscience). Primers for cytokine mRNA detection were from
Eurofins MEG Operon, Ebersberg, Germany (Table S2 in File S1)
and SYBR Green JumpStart Taq ReadyMix was from Sigma-
Aldrich. Gene expression of IL-23p19 subunit was analysed using
TaqMan probe-based PCR from Applied Biosystems.
Generation and Infection of Human Monocyte-derived
DC (mDC)
Blood from healthy donors was collected in the presence of
10 U/ml heparin (CP Pharmaceuticals Ltd, Wrexham, UK).
Peripheral blood mononuclear cells (PBMC) were obtained by
density gradient centrifugation on LymphoprepTM (AXIS-
SHIELD, Oslo, Norway). CD14+ monocytes were separated by
the magnetic bead method according to the manufacturer’s
instructions (Mini MACS; Miltenyi Biotec GmbH, Germany).
Cells were resuspended in complete media (RPMI with 10% FCS,
1% L-glutamine, and 1% penicillin-streptomycin solution) sup-
plemented with 50 ng/ml recombinant human IL-4 and 100 ng/
ml recombinant human GM-CSF (R & D Systems, Minneapolis,
USA). 0.56106 cells/ml monocytes were infected with bacterial
culture at an MOI of 10.
T Cell Responses
Splenocytes were harvested from the spleens of WT mice by
passing the spleen contents through a cell strainer (70 mm, BD
Falcon, BD Biosciences). Cells were washed with PBS and red
blood cells depleted using red blood cell lysing buffer. 0.56106/ml
splenocytes (in PBS) were labelled with CFSE [5-(and 6)-
Carboxyfluorescein diacetate succinimidyl ester] (eBioscience) to
a final concentration of 10 mM. DynabeadsH Mouse T-Activator
CD3/CD28 was added to CFSE-labelled splenocytes at a bead-to-
cell ratio of 1:5 then co-cultured with C. difficile-stimulated BMDCs
in a 96-well plate in a DC: splenocyte ratio of 1:10. Co-cultures
were incubated at 37uC for 72–96 h. Cells were co-stained with
anti-mouse CD4 PE-Cy5 (eBioscience) and analysed at 48, 72, and
96 h by flow cytometry gated on CD4+ cells.
Naive CD4+ T cells were isolated from spleen of OT-II
transgenic mice using MagCellect Mouse Naı¨ve CD4+ T Cell
Isolation Kit (R & D Systems, Inc.) and labelled with CFSE prior
to co-culture with C. difficile-stimulated BMDCs in the presence of
OVA323–339 peptide (Abgent, Inc., San Diego, USA) and 10 U/ml
recombinant mouse IL-2 (Invitrogen). Cells were co-stained with
anti-mouse CD4 PE-Cy5 (eBioscience) and analysed at 48, 72, and
96 h by flow cytometry gated on CD4+ T cells.
Statistical Analysis
Statistical analysis was performed using a two-way ANOVA
followed by Bonferonni post-test. A non-parametric t-test (Mann–
Whitney U-test) was performed on data from ex-vivo infections.
Data considered significant if only probability was p,0.05 using
GraphPad Prism version 5.00 (San Diego, CA).
Supporting Information
File S1 Figure S1, Cytotoxic effects of C. difficile toxins on HT-29
and Vero cell-lines. Semi-confluent HT-29 (A & B) and confluent
Vero cells (C & D) were co-cultured with 2-fold dilutions of filter
sterilised R20291, 630, 630Derm and its toxin mutant strains. The
end-point titre of each dilution series was scored at 8 h post-
infection. Data is presented as the mean 6 SEM, n = 3. *p,0.05,
**p,0.01 and ***p,0.001 represent significant difference from
uninfected control cells, ‘p,0.05 and ‘‘p,0.01 represent signif-
icant difference from the parental strain. CD37 is a non-toxigenic
strain. P values were obtained using ANOVA with Bonferroni
post-test analysis. Figure S2, Intracellular IFN-c and IL-17A
staining in CD4+ naı¨ve T cells in response to C. difficile-stimulated
BMDC. Naı¨ve OT-II CD4+ T cells were co-cultured with C.
difficile-stimulated BMDCs in the presence of OVA323–339 for 96 h.
Intracellular expression of CD4+ IFN-c and IL-17A was analysed
by flow cytometry. Data is presented as percentage of IFN-c+ (A)
and IL-17A+ (B) expressing cells. Data represent mean 6 SEM,
n = 3. *p,0.05, **/‘‘p,0.01 and ***p,0.001 represent significant
difference from uninfected control cells and significant inter-strain
difference. P values were obtained using ANOVA with Bonferroni
post-test analysis. Table S1, List of C. difficile strains utilised in this
study. Table S2, List of primers used in real-time PCR analysis.
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